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Abstract
Background: Chlamydia possess a unique family of autotransporter proteins known as the Polymorphic membrane proteins
(Pmps). While the total number of pmp genes varies between Chlamydia species, all encode a single pmpD gene. In both
Chlamydia trachomatis (C. trachomatis) and C. pneumoniae, the PmpD protein is proteolytically cleaved on the cell surface.
The current study was carried out to determine the cleavage patterns of the PmpD protein in the animal pathogen C.
abortus (termed Pmp18D).
Methodology/Principal Findings: Using antibodies directed against different regions of Pmp18D, proteomic techniques
revealed that the mature protein was cleaved on the cell surface, resulting in a100 kDa N-terminal product and a 60 kDa
carboxy-terminal protein. The N-terminal protein was further processed into 84, 76 and 73 kDa products. Clustering analysis
resolved PmpD proteins into three distinct clades with C. abortus Pmp18D, being most similar to those originating from C.
psittaci, C. felis and C. caviae.
Conclusions/Significance: This study indicates that C. abortus Pmp18D is proteolytically processed at the cell surface similar
to the proteins of C. trachomatis and C. pneumoniae. However, patterns of cleavage are species-specific, with low sequence
conservation of PmpD across the genus. The absence of conserved domains indicates that the function of the PmpD
molecule in chlamydia remains to be elucidated.
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Introduction
The family Chlamydiaceae are a diverse group of obligate
intracellular Gram-negative bacteria that cause a range of
pathogenic conditions in a wide variety of host species [1]. All
known members share a similar and distinct biphasic develop-
mental cycle, which is initiated with the entry of the infectious
form of the organism, the elementary body (EB), into the host cell
where it resides within a vacuole known as an inclusion. The EB
undergoes conversion to the metabolically active reticulate body
(RB), which replicates through binary fission. Towards the end of
the cycle (48 to 72 hours following infection) the RBs re-condense
to EBs before both the inclusion and host cell are lysed, allowing
the release of the infective organisms to infect neighbouring cells
[1].
The Type V or autotransporter (AT) secretion system comprises
the largest family of proteins found across pathogenic Gram-
negative bacteria. Classical AT structure is characterised by the
presence of three separate functional domains; a cleavable N-
terminal signal sequence; a passenger (effector) domain and a
carboxy-terminal b-barrel translocator domain [2]. While the
overall structure and organisation of ATs is similar across bacterial
species, the function of the effectors vary. However, many of these
proteins have been identified as virulence factors involved in
bacterial pathogenesis. Chlamydia possess a unique family of
proteins that have been identified as ATs (known as the
Polymorphic membrane proteins (Pmps)) [3]. Pmps were first
identified in Chlamydia abortus (C. abortus) due to their immuno-
reactivity with convalescent sheep sera [4,5], and have now been
identified in all of the pathogenic Chlamydia spp. Significant
heterogeneity of Pmp gene carriage has been observed between
chlamydial species. Genome sequencing of C. trachomatis has
revealed the presence of 9 pmp genes (termed A-I) [6] while 21, 16,
18, 17, 21 and 20 pmps have been identified in C. pneumoniae, C.
pecorum, C. abortus, C. caviae, C. psittaci and C. felis respectively [7–
11].
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The PmpD proteins of both C. trachomatis and C. pneumoniae are
expressed throughout the chlamydial developmental cycle. Pmps
are highly immunogenic and there has been much interest in their
exploitation as vaccine and diagnostic candidates. Recently,
attention has been focussed upon PmpD due to the ability of
antibodies raised against it to neutralize the infectivity of both C.
trachomatis and C. pneumoniae in vitro, and the level of seroconversion
to the protein observed in C. trachomatis infected individuals. PmpD
is cleaved, and it has been hypothesised that this may permit
secretion of specific effector peptides into host cells or within the
inclusion [12]. However, little is understood about the function or
processing of the PmpD molecule in any other Chlamydia spp.
This study focuses on C. abortus, the causative agent of ovine
enzootic abortion (OEA), a disease of significant economic
importance to the sheep rearing industry and of concern to
human health, particularly pregnant women [13]. The pmp genes
are grouped within specific families by their phylogenetic similarity
with the originally identified C. trachomatis pmps [14]. However, due
to the expansion in pmp gene number in C. abortus, the pmps have
additionally been numbered sequentially by their position in
genome, with the C. abortus PmpD protein being termed Pmp18D
[8]. Given the potential conservation of roles of the PmpD
molecules across chlamydial species studied to date and their
potential as diagnostic or vaccine candidates, this study was
carried out to investigate the structural features and processing of
the C. abortus Pmp18D molecule.
Materials and Methods
C. abortus propagation
McCoy cells were obtained from the European Collection of
Cell Cultures (ECACC, Salisbury, UK) and maintained in
RPMI1640 medium supplemented with 10% heat inactivated
fetal calf serum (PAA Laboratories Ltd, Yeovil, Somerset, UK).
The C. abortus strain S26/3 was propagated in McCoy cells,
according to a previously published protocol [15].
Antibodies and Western blotting
Rabbit polyclonal antibodies were generated against C. abortus
S26/3 Pmp18D peptides: N-Pmp18D (N terminal region of
Pmp18D) EKPIHAQGPKKGETD (amino acids (aa) 67–81);
Mid-Pmp18D (middle domain region of Pmp18D) DPNAKPTE-
KIESPTS (aa 1052–1066) (both Eurogentec, Southampton, UK);
C-Pmp18D (carboxy terminus region of Pmp18D)
CQPNLGGSKGSWDSR (aa 1357–1370) (Genscript USA Inc.,
Piscataway, NJ, USA). In addition, the mouse anti-Omp-1 mAb
4/11 [16] was used for the detection of C.abortus Omp-1. Total cell
lysates were prepared by scraping infected S26/3 infected McCoy
monolayers and pelleting at 12,000 rpm in a microcentrifuge at
24, 48 or 72 h post-infection (p.i.). The resulting pellets were
resuspended in 1 ml 16Laemmli loading buffer [17]. After brief
sonication and boiling for 5 mins, proteins were separated on 4–
12% NuPAGE gels (Life Technologies, Paisley, UK), transferred
onto nitrocellulose and Western blotted. Detection was accom-
plished using the ECL-advance system and results were visualized
using the LAS400 Quantitative imaging system (both GE
Healthcare, Chalfont St Giles, Buckinghamshire, UK). Molecular
masses of recognized protein products were calculated using a
standard curve, calculated from the Rf values obtained for
SeeBlueH Plus2 markers (Life Technologies) and using Image-
Quant TL 1D-PAGE analysis software (GE Healthcare).
Pmp18D solubility in infected McCoy cells
To investigate if Pmp18D protein fragments are released or
retained on the surface of the C. abortus outer membrane, soluble
and insoluble protein fractions from C. abortus infected cells were
prepared essentially as previously described [12]. Briefly, infected
225 cm2 flasks of McCoy cell monolayers were harvested at 48 h
post-infection and washed with 5 ml hypotonic swelling buffer
(15 mM KCl, 1.5 mM Mg(Ac)2 and 10 mM HEPES, pH 7.4)
containing protease inhibitors (Sigma Aldrich, Dorset, UK;
P9549). Cells were gently lysed by 20 strokes using a Dounce
homogenizer. The homogenate was briefly centrifuged for 5 mins
at 2006 g and the resulting supernatant further centrifuged at
125,0006 g (SW55Ti rotor Beckman Coulter). The supernatant
(soluble material) was removed and the protein precipitated with 3
volumes of acetone at 220uC. The pellet (insoluble material) was
washed twice with ice-cold PBS containing protease inhibitors
before lysis in 1 ml 16Laemmli loading buffer. The precipitated
supernatant material was subsequently lysed in the same volume of
16 Laemmli buffer. Samples were analysed by Western blotting,
as described above.
Identification of major high molecular weight cleavage
products
Identification of the major passenger cleavage products was
accomplished using 2 independent proteomic methods:
Liquid chromatography-electrospray ionisation-tandem
mass spectrometry (LC-ESI-MS/MS)
For the initial identification of the cleavage products, replicate
100 ml samples of S26/3 infected total cell lysate were separated
on a 7% 16 cm Slab gel (Hoefer SE600, GE Healthcare). The gel
was cut into two equal pieces. One half was blotted onto
nitrocellulose using a semi-dry blotting apparatus prior to Western
blotting using the 3 antibodies directed against the different
regions of Pmp18D. The second half of the gel was stained with
SimplyblueTM SafeStain (Life Technologies). The position of the
identified bands was determined and the gel slices excised from the
gel. Proteins were destained and reductively alkylated using DTT
and iodoacetamide. Gel slices were then digested overnight with
trypsin (Porcine trypsin, Promega, Hants, UK) at 37uC. Samples
were transferred to low-protein-binding HPLC sample vials and
stored at 4uC until required for LC-ESI-MS/MS analysis. Liquid
chromatography was performed using an Ultimate 3000 nano-
UHPLC system (Dionex) comprising a WPS-3000 well-plate
micro auto sampler, a FLM-3000 flow manager and column
compartment, a UVD-3000 UV detector, an LPG-3600 dual-
gradient micropump and an SRD-3600 solvent rack controlled by
Chromeleon chromatography software (Dionex). A micro-pump
flow rate of 246 ml/min was used in combination with a cap-flow
splitter cartridge, affording a 1/82 flow split and a final flow rate of
3 ml/min through a 5 cm6200 mm ID monolithic reversed phase
column (Dionex) maintained at 50uC. Samples of 4 ml were
applied to the column by direct injection. Peptides were eluted by
the application of a 15 min linear gradient from 8–45% solvent B
(80% acetonitrile, 0.1% (v/v) formic acid) and directed through a
3 nl UV detector flow cell. LC was interfaced directly with a 3-D
high capacity ion trap tandem mass spectrometer (amaZon ETD,
Bruker Daltonics) via a low-volume (50 ml/min maximum)
stainless steel nebuliser (Agilent, cat. no.G1946-20260) and ESI.
Parameters for tandem MS analysis were set as previously
described [18] with minor modifications as detailed below.
Database Mining: Deconvoluted MS/MS data in Mascot
generic file (mgf) format was imported into ProteinScapeTM
Processing of C. abortus Pmp18D
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analysis software (Bruker Daltonics) and searched against the
C.abortus_NCBInr database utilising the Mascot (Matrix Science)
search algorithm. The data was also searched specifically against
the cognate pmp18D protein sequence using the Sequence-Editor
function of BiotoolsTM analysis software (Bruker Daltonics). The
interpretation of MS/MS data was performed in accordance with
published guidelines [19]. To this end, fixed (carbamidomethyl C)
and variable (deamidation N,Q and oxidation M) modifications
were selected, and mass tolerance values for both MS and MS/MS
were set at 60.5 Da allowing for one 13C isotope and a single
missed cleavage. Molecular weight search (MOWSE) scores and
percentage coverage values attained for individual protein
identifications were inspected manually and considered significant
only if a) two peptides were matched for each protein, and b) each
peptide contained an unbroken ‘‘b’’ or ‘‘y’’ ion series of a
minimum of four amino acid residues.
Matrix-assisted laser desorption/ionization- time of flight
mass spectrometry (MALDI-ToF MS)
Infected McCoy cell monolayers were disrupted with sterile
glass beads, and was briefly sonicated, prior to centrifugation at
1000 rpm for 10 minutes in a JA-14 rotor (Beckman Coulter), to
remove gross cellular debris. The supernatant was removed and
centrifuged at 12000 rpm for 40 minutes at 4uC using a JA-16.250
rotor. The pellet was resuspended in 5 ml 2% sarcosyl/PBS by
brief sonication before incubation at 37uC for 30 minutes. The
suspension was then centrifuged at 120,0006 g using a SW55Ti
rotor for 60 minutes at 4uC. The supernatant was removed and
used for Pmp18D purification. Immunoprecipitation was carried
out using Protein G DynabeadsH (Life Technologies) coupled to
Pmp18D antibodies, as per the manufacturer’s instructions. The
final antibody:protein complex was disassociated by the addition
of Laemmli loading buffer and heating at 95uC. Proteins were
resolved on NuPAGEH polyacrylamide gels and visualised using
SimplyblueTM SafeStain (both Life Technologies). Gel slices were
treated as described for LC-ESI-MS-MS analysis. Digests were
analysed on a Bruker Ultraflex II MALDI-ToF-ToF mass
spectrometer (Bruker Daltonics), scanning the 600 to 5000 dalton
region in reflectron mode producing monoisotopic resolution. The
spectra generated were mass calibrated using known standards.
Masses obtained were then database searched using the MAS-
COT search algorithm.
Bioinformatic analysis of PmpD
PmpD amino acid sequences were obtained from GenBank and
NCBI conserved domain searches were performed to define
passenger-, M- and autotransporter-domains. PmpD sequences
from the passenger-, and combined M- and autotransporter-
domains were aligned using MUSCLE [20], and checked by
mapping YASPIN secondary structure predictions [21] before
being joined into a single alignment. Regions which could not be
unambiguously aligned were eliminated using GBlocks v 0.91b
[22], resulting in 1032 positions being analyzed (59% of the
original 1726 positions). Bayesian dendrograms were generated
using MrBayes software [23], launched from the TOPALi v2.5
package [24] using the CPRev+I+G substitution model that was
determined to be the model of best fit, based on the BIC criterion.
Trees were generated using Markov chain Monte Carlo (MCMC)
settings of 2 runs of 625,000 generations with a burn-in of 125,000
generations with trees sampled every 100 runs.
Results
Expression of Pmp18D
Western blot analysis using all 3 anti-Pmp18D antibodies
demonstrated that expression of Pmp18D was time-dependent and
correlated with an increase in Omp-1 levels over time (Figure 1).
At any of the analyzed time points, using both the N-Pmp18D and
Mid-Pmp18D antibodies, little if any intact 160 kDa molecular
mass protein (which would correspond to the mature Pmp18D
molecule) could be observed. The most highly immunoreactive
protein among the identified bands was a molecule of approxi-
mately 94 kDa that was recognised by both N-Pmp18D and Mid-
Pmp18D (Figures 1a and 1b respectively) and a 50 kDa protein
recognised by the C-Pmp18D (Figure 1c) antibody alone.
Additional protein bands at approximately 84 kDa and a doublet
of a 76 kDa and 73 kDa were also routinely recognised by the
Mid-Pmp18D antibody, particularly by 72 h p.i. (Figure 1b).
However none of these additional bands were recognised by the
N-Pmp18D antibody (Figure 1a).
Pmp18D solubility in infected McCoy cells
To determine whether the Pmp18D passenger is secreted from
C. abortus or retained on the bacterial surface, soluble and insoluble
cell fractions were prepared from C. abortus-infected McCoy cells at
Figure 1. Western blot demonstrating an increase in Pmp18D
expression and proteolytic cleavage over the 72 h C. abortus
developmental cycle using: a) anti-N-Pmp18D, b) anti-Mid-
Pmp18D, c) anti-C-Pmp18D pAbs and d) anti-Omp-1 mAb 4/11.
doi:10.1371/journal.pone.0049190.g001
Processing of C. abortus Pmp18D
PLOS ONE | www.plosone.org 3 November 2012 | Volume 7 | Issue 11 | e49190
48 and 72 h p.i.. At both time points Omp-1 could be only
identified in the insoluble fraction (Figure 2d), as could the 50 kDa
band identified by the C-Pmp18D antibody (Figure 2c). The
greater proportion of the protein bands recognised by both N-
Pmp18D and Mid-Pmp18D antibodies was identified solely in the
insoluble fraction. However, a small proportion of the 94 kDa
product could also be detected in the soluble material (Figures 2a
and 2b).
Proteomic identification of Pmp18D products
Proteomic analysis was carried out to identify the protein bands
recognised by the different antibodies targeting the various regions
of Pmp18D. The passenger domain was found to be readily
soluble in 2% sarkosyl (Figure S1) and the protein identification of
these N-terminal bands was successfully accomplished using two
independent techniques, LC-ESI-MS-MS and MALDI ToF MS
using both N-Pmp18D and Mid-Pmp18D antibodies. Immuno-
precipitation prior to MALDI ToF MS using the C-Pmp18D
antibody was not successful and so only LC-ESI-MS-MS could be
used to identify bands recognised using this antibody.
While 4 bands could be identified by Western blot using the
Mid-Pmp18D antibody, only the protein sequence of the 2 most
immunoreactive protein bands at approximately 94 kDa and
84 kDa could be determined by LC-ESI-MS-MS, and these were
the only 2 proteins recovered by immunoprecipitation prior to
MALDI-ToF MS analysis. These combined analyses gave broadly
similar results, although peptide coverage with MALDI-ToF MS
analysis appeared to be slightly greater. MALDI-ToF MS analysis
identified the same peptide at the carboxy-terminus of both
proteins, NAKPTEK1060 and this was confirmed by LC-ESI-MS-
MS. The first detected N-terminal peptide sequence of the larger
94 kDa protein fragment, recognised by both N-Pmp18D and
Mid-Pmp18D, was identified as 67EKPIHAQ by MALDI ToF
MS and as 76KGETDQ by LC-ESI-MS-MS, giving a predicted
molecular mass for this protein fragment of approximately
104 kDa based on sequence coverage (Figure S2a). Both methods
identified the same initial peptide at the N-terminus of the
predicted 84 kDa protein, with peptide coverage starting from
215LVDGCE, indicating that it is a product of the initial larger
protein with cleavage at the N-terminus and the removal of
approximately 150 amino acids (Figure S2b) giving an actual
predicted molecular mass of 87.5 kDa.
No protein could be recovered after immunoprecipitation using
the carboxy antibody. However, LC-ESI-MS/MS analysis dem-
onstrated sequence coverage of the 50 kDa fragment identified by
the carboxy antibody from 1083TLADIN to LNCGMR1518 with a
predicted molecular mass based on sequence coverage of 48 kDa
(Figure S2c). A further cleavage product of the carboxy-terminal
barrel was also identified with an initial peptide at 1083TLADIN
with sequence coverage obtained to EHNYSR1445 (Figure S2d).
The sizes of the predicted proteins remain approximate and are
perhaps slightly underestimated as the peptides identified using
both these techniques may not provide the actual first or last
peptide sequences of the analysed proteins. A schematic diagram
of the approximate cleavage sites for each of the identified PmpD
protein fragments is shown in Figure 3.
Bioinformatic analysis of PmpD
To determine whether the cleavage products observed in C.
abortus Pmp18D and other Chlamydia spp occurred in conserved
regions or motifs of the PmpD molecule, we performed an
alignment and clustering analysis of PmpD protein sequences from
the nine Chlamydia spp.
Clustering analysis of PmpD identified in the nine Chlamydia
spp. showed that proteins group into three distinct lineages, each
strongly supported with posterior probabilities of 1.00, consisting
of cluster 1: C. abortus, C. felis, C. caviae and C. psittaci; cluster 2: C.
pecorum and C. pneumoniae; and cluster 3: C. muridarum, C. trachomatis
and C. suis (Figure 4). Within each lineage, PmpD clustered by
species with the exception of C. suis which clustered with C.
trachomatis serovar E strains. Mapping of N-terminal peptides
identified in C. abortus onto PmpD sequence alignments demon-
strated the M-domain cleavage site 1083TLADIN to occur in a
species-variable region located between two flanking regions of
high sequence conservation (Figure S3a). The cleavage site
identified by peptide EHNYSR1445 occurred in a region of high
sequence conservation between all Chlamydia spp., whereas
peptides LNCGMR1518 and 215LVFDGCE, located in the barrel-
and passenger domains respectively, occurred in semi-conserved
regions flanked by regions of high sequence conservation (Figure
S3b and c). The cleavage site identified in the passenger domain
by peptide 67EKPIHAQ occurred in a region of unique sequence
composition in C. abortus (Figure S2d).
Discussion
Although pmp gene carriage across Chlamydia spp. is variable
through gene expansion and diversification in a number of pmp
families, the genome of each species encodes only one pmpD gene.
Our previous work has demonstrated that Pmp18D in C. abortus
follows the same patterns of expression at both the transcript [25]
and protein level [26] as PmpD of C. trachomatis. It was
hypothesised that given these similarities in protein expression,
the proteolytic processing of C. abortus Pmp18D would resemble
that of the other previously studied PmpD molecules.
The results from previous studies on C. trachomatis [12,27] and C.
pneumoniae PmpD [28] together with those from this current study
on C. abortus PmpD, demonstrate that there is a degree of
heterogeneity in the processing of PmpD between species. At
various time-points, full-length PmpD can be identified during the
C. trachomatis developmental cycle. However, little if any full-length
protein could be observed at any of the analysed time points in C.
abortus, mirroring the observations made on the processing of the
C. pneumoniae PmpD [28]. Due to differences in the timing of the
chlamydial developmental cycle between species, direct compar-
ison of specific time points is difficult and it cannot be discounted
that full-length Pmp18D may have been observed with the analysis
of additional time-points. However, the results from the current
study suggest that virtually all of the Pmp18D in C. abortus is
cleaved directly upon translocation to the outer surface of the
Figure 2. Western blot demonstrating the presence of the
majority of Pmp18D in the insoluble material after sonication
in PBS 48 h post-infection: a) anti-N-Pmp18D, b) anti-Mid-
Pmp18D, c) anti-C-Pmp18D and d) anti-Omp-1 mAb 4/11.
doi:10.1371/journal.pone.0049190.g002
Processing of C. abortus Pmp18D
PLOS ONE | www.plosone.org 4 November 2012 | Volume 7 | Issue 11 | e49190
bacterium, comprising the passenger domain with a molecular
mass of approximately 104 kDa and a 48 kDa protein comprising
the M-domain and the carboxy-terminal b-barrel domain. The
majority of these products appear to remain associated with the
outer membrane of the organism, as only a small proportion of the
cleaved 104 kDa molecule could be identified in the soluble
fraction.
Evidence from both Western blotting and proteomic methods
has revealed further cleavage at the N-terminus of the 104 kDa
protein. The Mid-Pmp18D antibody recognised an additional 3
protein bands, a single band of approximately 84 kDa and a
doublet of 76 and 73 kDa that were not recognised by the N-
terminal antibody. The smaller protein fragments cleaved from
these proteins including the N-terminal 150aa polypeptide cleaved
from the 104 kDa protein could not be subsequently identified in
any cellular fraction. It has been previously hypothesised in C.
trachomatis that some products of PmpD cleavage could act as
soluble effector molecules [12]. These effectors could either impact
on host transcription or cell lysis or be secreted from the host cell
during the latter stages of the chlamydial developmental cycle.
Certainly, the observed increase in the levels of the cleaved N-
terminal proteins 72 h post-infection would fit with this hypothesis.
However, while cleavage of the passenger domains appears to be a
conserved feature of the PmpD molecule across Chlamydia spp.,
patterns of cleavage appear to be species-specific. Therefore, to
understand whether the differences in cleavage patterns could be
related to the presence of conserved regions or motifs within the
molecule, an analysis of representative PmpD amino acid
sequences was carried out to determine sequence similarity across
species. Phylogenetic analysis of PmpD revealed a high degree of
amino acid sequence heterogeneity between Chlamydia spp.,
particularly within the passenger domains. The identification of
distinct clades of PmpD molecules comprising 3 clusters (Cluster 1:
C. abortus, C. psittaci, C. caviae and C. felis; Cluster 2: C. pneumoniae
and C. pecorum and Cluster 3: C. trachomatis, C. suis and C.
muridarum), could indicate a different function for PmpD for the
species belonging to these different clusters. Indeed, in addition to
difference in amino acid sequence and proteolytic processing,
Swanson and colleagues [12] highlighted the presence of putative
RGD and NLS domains within specific cleavage products of C.
trachomatis PmpD [12]. These motifs are maintained in C. suis
PmpD, which has 100% similarity in terms of amino acid
sequence to that of C. trachomatis serovar E. However, neither of
these motifs were identified in Pmp18D of C. abortus, and of the
other sequenced members of the Chlamydiaceae, the NLS motif
could only be identified in C. felis, although in a different location
within the protein. The differences in cleavage patterns and the
absence of conserved motifs in PmpD across species suggests that
the protein may play different roles in different species of
Chlamydia.
Cleavage of the PmpD molecule appears to be a conserved
feature across the chlamydial species published to date. However,
the patterns of proteolytic cleavage appear to be species-specific
and phylogenetic analyses show large scale variation of PmpD
Figure 3. Schematic representation of Pmp18D cleavage products as revealed following proteomic analysis of protein fragments.
doi:10.1371/journal.pone.0049190.g003
Processing of C. abortus Pmp18D
PLOS ONE | www.plosone.org 5 November 2012 | Volume 7 | Issue 11 | e49190
within the Chlamydiaceae, with few conserved motifs between species
in processing regions. Further studies are required to elucidate the
function of PmpD and investigate whether this function is
conserved across the different Chlamydia spp.
Supporting Information
Figure S1 Western blot demonstrating the solubility of
the Pmp18D N-terminal passenger domain in 2%
sarkosyl (using the Mid-Pmp18D antibody). Lane 1 Whole
C. abortus Elementary bodies (EBs); Lane 2 Soluble fraction after
treatment of whole EBs with 2% sarkosyl; Lane 3 Soluble fraction
after treatment of sarkosyl insoluble pellet with 1mM DTT/2%
Sarkosyl; Lane 4 Sarkosyl insoluble material.
(PDF)
Figure S2 Peptide coverage of Pmp18D protein cleavage
products as determined by LC-ESI-MS-MS and MALDI
ToF MS.
(PDF)
Figure S3 Region alignments of predicted cleavage sites
in C. abortus Pmp18D.
(DOC)
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